article

1. Influence of induction therapy and antiretroviral regimen on outcomes in kidney transplant recipients living with human immunodeficiency..  Transplant infectious disease : an official journal of the Transplantation Society.  26:-. 2024
2. CMV IgG is Associated with Physical Function but not Muscle Density in People with HIV..  Journal of acquired immune deficiency syndromes (1999).  95:470-478. 2024
3. Disseminated Scedosporium infection in the early post-kidney transplant period..  Transplant infectious disease : an official journal of the Transplantation Society.  26:-. 2024
4. Patient years lost due to cytomegalovirus serostatus mismatching in the scientific registry of transplant recipients..  Frontiers in immunology.  -. 2024
5. Cytomegalovirus Immune reconstitution in cord blood transplant recipients on letermovir prophylaxis..  Transplant infectious disease : an official journal of the Transplantation Society.  25:-. 2023
6. Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology..  Transplantation and cellular therapy.  29:10-18. 2022
7. Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)..  Transplantation and cellular therapy.  28:810-821. 2022
8. Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study..  Open forum infectious diseases.  9:-. 2022
9. Cognitive impairment burden in older and younger adults across the kidney transplant care continuum..  Clinical transplantation.  35:-. 2021
10. Perioperative anidulafungin combined with triazole prophylaxis for the prevention of early invasive candidiasis in lung transplant recipients..  Transplant infectious disease : an official journal of the Transplantation Society.  23:-. 2021
11. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium..  Annals of oncology : official journal of the European Society for Medical Oncology.  32:787-800. 2021
12. Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents..  Open forum infectious diseases.  8:-. 2020
13. Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients..  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.  26:1983-1994. 2020
14. Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase Mutation..  Hepatology (Baltimore, Md.).  72:356-358. 2020
15. Cytomegalovirus myocarditis in solid organ transplant recipients: A case series and review of literature..  Transplant infectious disease : an official journal of the Transplantation Society.  22:-. 2020
16. Severe acute Q fever pneumonia complicated by presumed persistent localized Q fever endocarditis in a renal transplant recipient: A case report and review of the literature..  Transplant infectious disease : an official journal of the Transplantation Society.  22:-. 2019
17. Toxoplasmosis in non-cardiac solid organ transplant recipients: A case series and review of literature..  Transplant infectious disease : an official journal of the Transplantation Society.  22:-. 2019
18. Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation..  Bone marrow transplantation.  55:780-786. 2019
19. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population..  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.  25:2091-2097. 2019
20. Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study..  Bone marrow transplantation.  54:1354-1360. 2019
21. Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with Ruxolitinib..  Case reports in hematology.  -. 2016
22. Mycobacterium mucogenicum bacteremia in immune-compromised patients, 2008-2013..  Diagnostic microbiology and infectious disease.  85:182-5. 2016
23. DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation..  Case reports in medicine.  -. 2016
24. Morbidity and mortality attributable to Rothia bacteremia in neutropenic and nonneutropenic patients..  Diagnostic microbiology and infectious disease.  85:116-20. 2016
25. Gastrointestinal mucormycosis in immunocompromised hosts..  Mycoses.  58:714-8. 2015
26. CYP2C19*17 genetic polymorphism--an uncommon cause of voriconazole treatment failure..  Diagnostic microbiology and infectious disease.  83:46-8. 2015
27. Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies..  Mycoses.  57:687-98. 2014
28. Mucormycosis in patients with inflammatory bowel disease: case series and review of the literature..  Case reports in medicine.  -. 2014
29. Helicobacter canis bacteremia in a patient with fever of unknown origin..  Journal of clinical microbiology.  51:1046-8. 2013